Actemra 162 mg PFS
$1,050.23
$631.15
Actemra 162 mg PFS is an injectable medication designed to effectively manage various inflammatory conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriasis, ulcerative colitis, and Crohn's disease. This innovative treatment belongs to the class of disease-modifying anti-rheumatic drugs (DMARDs) and functions as a monoclonal antibody that targets and inactivates tumor necrosis factor-alpha (TNFα), a key player in the inflammatory process. By doing so, Actemra significantly alleviates symptoms like swelling, pain, and redness, ultimately enhancing overall physical function and quality of life for patients. It is important to be aware of potential side effects, including an increased risk of infections and changes in liver enzyme levels, which necessitate regular monitoring during treatment. As a vital option in the realm of immunotherapy, Actemra offers hope for those struggling with chronic inflammatory diseases. Before starting this medication, consulting with a healthcare professional is crucial to ensure it aligns with your individual health needs. With its proven efficacy, Actemra 162 mg PFS stands out as a reliable choice for managing debilitating autoimmune disorders.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Actemra 162 mg pfs is primarily indicated for the treatment of moderate to severe rheumatoid arthritis in adults. This medication helps reduce inflammation and joint pain, improving overall physical function. By targeting specific pathways in the immune system, Actemra 162 mg pfs can provide significant relief for patients struggling with this chronic condition. Regular administration may enhance the quality of life for those affected.
• In addition to rheumatoid arthritis, Actemra 162 mg pfs is utilized for treating juvenile idiopathic arthritis in children. This condition can severely impact a child's growth and development due to joint pain and swelling. By effectively managing symptoms, Actemra 162 mg pfs supports better mobility and allows children to engage in daily activities more comfortably. Early intervention with this treatment can lead to improved long-term outcomes.
• Actemra 162 mg pfs is also prescribed for individuals with active psoriatic arthritis, a condition that combines joint inflammation with skin manifestations. This medication helps in alleviating both joint pain and skin lesions associated with the disease. By addressing the underlying inflammatory processes, Actemra 162 mg pfs assists patients in achieving better control of their symptoms. This dual-action can significantly enhance the patient's overall well-being.
• Another important use of Actemra 162 mg pfs is in the treatment of giant cell arteritis, a condition characterized by inflammation of the blood vessels. This medication helps to reduce the risk of complications associated with the disease, such as vision loss or stroke. By modulating the immune response, Actemra 162 mg pfs can provide rapid relief from symptoms and help prevent flare-ups. Patients receiving this treatment often experience a significant improvement in their condition.
Benefits
Rheumatoid arthritis: Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects the joints. It causes inflammation, pain, stiffness, and swelling in the joints, and can also affect other parts of the body, such as the skin, eyes, lungs, heart, and blood vessels. Actemra 162 mg helps reduce inflammation and manage the symptoms of Rheumatoid arthritis.
Ankylosing spondylitis: Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine, causing pain, stiffness, and reduced mobility. It is a form of arthritis that mainly affects the joints between the vertebrae in the spine and the sacroiliac joints where the spine connects to the pelvis. Actemra 162 mg Injection works by targeting and inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing the inflammation associated with ankylosing spondylitis, Actemra 162 mg PFS can help relieve pain, stiffness, and other symptoms of the condition.
Crohn's disease: Crohn's disease is a chronic inflammatory bowel disease (IBD) that primarily affects the gastrointestinal tract. It can cause inflammation and damage to any part of the digestive system, from the mouth to the anus. Symptoms of Crohn's disease can vary but commonly include abdominal pain, diarrhoea, weight loss, fatigue, and loss of appetite. Actemra 162 mg works by targeting and inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the gastrointestinal tract, Actemra 162 mg PFS can help manage the symptoms of Crohn's disease, including abdominal pain, diarrhoea, and inflammation.
Ulcerative colitis: Ulcerative colitis is a chronic inflammatory bowel disease that primarily affects the colon and rectum. Actemra 162 mg Injection can help reduce inflammation in the gastrointestinal tract and manage the symptoms of ulcerative colitis.
Hidradenitis suppurativa: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that affects the hair follicles in areas of the body with a high concentration of sweat glands, such as the armpits, groin, and buttocks. Actemra 162 mg works by targeting and inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation, Actemra 162 mg PFS can help alleviate symptoms and prevent the progression of hidradenitis suppurativa.
Juvenile idiopathic arthritis: Juvenile idiopathic arthritis (JIA) is a type of arthritis that occurs in children under the age of 16 and persists for at least six weeks. It is characterized by joint inflammation, pain, stiffness, and swelling. Actemra 162 mg PFS works by inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the joints, adalimumab helps manage the symptoms of Juvenile idiopathic arthritis, including pain, stiffness, and swelling. Plaque psoriasis: Psoriasis is a condition where the skin cells in the body grow too quickly and form scales and dry patches. They can grow anywhere, but most appear on the scalp, elbows, knees, and lower back. Actemra 162 mg Injection reduces the scaly, itchy patches which may develop on the different parts of the body. It may take several months to become fully effective. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Psoriatic arthritis: Psoriatic arthritis is a type of inflammatory arthritis that occurs in some individuals with psoriasis, a chronic skin condition. It causes joint pain, swelling, and stiffness, and can affect any joint in the body. Actemra 162 mg PFS works by inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the joints, adalimumab can help manage the symptoms of psoriatic arthritis, including joint pain, stiffness, and swelling.
Uveitis: Uveitis refers to the inflammation of the uvea, which is the middle layer of the eye. It can affect various parts of the uvea, including the iris, ciliary body, and choroid. Actemra 162 mg is a tumour necrosis factor (TNF) inhibitor that helps reduce inflammation by targeting TNF, a protein involved in the immune response.
Side Effects
As with all medicines, Actemra 162 mg PFS may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. If they persist or you're concerned about them, tell your doctor.
Most Common Side Effects
• Diarrhoea
• Headache
• Throat, Nasal and Chest infections
• Skin infections
• Tiredness
• Yellow Eyes and Skin.
• Appetite loss
• Vomiting
• Darker Urine and Tarry stool
• skin rashes
• Short breathing
• Chest pain
• Coughing and Sneezing with blood and Mucus
• redness and Swelling of Skin
• painful Urination
• Weigh loss
• Changes in Frequency and Consistency of passing stool.
Common Side Effects
• Blood Clots
• sudden shortness of Breath
• Painful Breathing
• Chest Pain
• Heavy Sweating
• Redness, Painful and Swollen limbs.
How To Use
Actemra 162 mg PFS is given subcutaneously (under the skin) from any health care professional. Dosage and frequency will be decided by your doctor as per your disease condition and several other factors.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Actemra 162 Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: patients with kidney disease should closely monitor kidney function while taking Actemra 162 mg PFS and report any unusual symptoms or changes in kidney function to their physician. The dose of Actemra 162 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: Actemra 162 mg is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
• Liver: Actemra 162 mg PFS should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Actemra 162 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Actemra 162 Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Actemra 162 mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects on the developing baby; however, there are limited human studies.
• Driving: Actemra 162 mg PFS may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Actemra 162 mg.